(Q50701758)

English

Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.

scientific article published on 12 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

based on heuristic

inferred from title

fludarabine phosphate

1 reference

based on heuristic

inferred from title

bladder neoplasm

1 reference

based on heuristic

inferred from title

tumour xenograft

1 reference

based on heuristic

inferred from title

Escherichia coli

1 reference

based on heuristic

inferred from title

Bernard H Bochner

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

S Menendez

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

C Ozu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

M Ohori

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

C Cordon-Cardo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

C R Logg

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

N Kasahara

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

12 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

279-286

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218950%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701013

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

Adenovirus-mediated suicide gene therapy for experimental bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

Constitutive production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19): possible demonstration of totipotential differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays (February 17, 1993).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

Converting cancer genes into killer genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

21 January 2018

A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701013

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50701758&oldid=1792333635"